Aurora Cannabis (ACB) EBIAT (2017 - 2025)
Aurora Cannabis has reported EBIAT over the past 9 years, most recently at -$1.4 million for Q4 2025.
- Quarterly EBIAT fell 106.75% to -$1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$56.3 million through Dec 2025, down 705.25% year-over-year, with the annual reading at $11.0 million for FY2025, 121.35% up from the prior year.
- EBIAT was -$1.4 million for Q4 2025 at Aurora Cannabis, up from -$38.5 million in the prior quarter.
- Over five years, EBIAT peaked at $20.2 million in Q4 2024 and troughed at -$799.1 million in Q1 2022.
- The 5-year median for EBIAT is -$17.3 million (2024), against an average of -$98.7 million.
- The largest YoY upside for EBIAT was 251.97% in 2024 against a maximum downside of 3056.05% in 2024.
- A 5-year view of EBIAT shows it stood at -$59.6 million in 2021, then rose by 16.98% to -$49.5 million in 2022, then soared by 73.14% to -$13.3 million in 2023, then soared by 251.97% to $20.2 million in 2024, then plummeted by 106.75% to -$1.4 million in 2025.
- Per Business Quant, the three most recent readings for ACB's EBIAT are -$1.4 million (Q4 2025), -$38.5 million (Q3 2025), and -$14.3 million (Q2 2025).